Global private equity and venture capital news and research

Private equity-backed Omega Pharma clinches €470m GSK portfolio $

16 Mar 2012

Omega Pharma , the Belgian pharmaceutical group backed by Dutch buy-out firm Waterland, has clinched a deal to buy a €470m portfolio of over-the counter drugs owned by British pharma giant GlaxoSmithKline.

Sorry, you have reached your quota of 1 free article a week or you are attempting to read a Premium story.

To access the latest news and PREMIUM stories for FREE download the new AltAssets mobile app from the Google Play or App Store.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016